Histoplasmosis in cats demands long treatment and early suspicion

Histoplasmosis in cats is getting renewed attention as a difficult-to-diagnose fungal disease that can demand months of treatment and careful client counseling. The PetMD article highlights the core clinical message: this is a potentially disseminated infection caused by Histoplasma capsulatum, often linked to contaminated soil, and affected cats may need prolonged antifungal therapy with no guarantee of cure. That framing aligns with current veterinary references, which continue to list itraconazole as the treatment of choice in most feline cases. (merckvetmanual.com)

The disease has long been recognized in dogs and cats, but it remains easy to miss because presentation is variable. Merck notes that histoplasmosis is uncommon overall, yet cats and dogs are the species most often affected among domestic animals. In cats, respiratory and gastrointestinal signs are common, but dissemination to the liver, spleen, lymph nodes, bone marrow, eyes, skin, and other organs can complicate the picture. That broad clinical range helps explain why cases may initially be mistaken for inflammatory bowel disease, neoplasia, asthma, or bacterial pneumonia. (merckvetmanual.com)

On treatment, the evidence base is still limited. Merck states that itraconazole is the treatment of choice for disseminated histoplasmosis in dogs and cats, while Cornell’s feline health resource says oral itraconazole or fluconazole is generally given for an average of about six months. Older published data indexed in PubMed found itraconazole to be well tolerated and effective in a small feline series, but larger retrospective studies suggest outcomes are mixed, with reported mortality rates around one-third to nearly one-half in some cohorts. That helps explain why consumer-facing summaries describe success as far from assured. (merckvetmanual.com)

Diagnosis and monitoring remain practical pain points. Cytology or histopathology demonstrating yeast organisms is often central to confirmation, while antigen testing can support the workup in some cases. Los Angeles County’s 2024 animal health advisory on locally acquired histoplasmosis in cats and dogs noted that diagnosis typically relies on clinical signs plus diagnostic testing, and that urine antigen testing can be helpful. The same advisory is also a reminder that clinicians shouldn’t assume histoplasmosis is confined to traditional endemic maps. CDC materials for human medicine similarly note that cases can occur across U.S. regions and that geographic range may be shifting, likely influenced in part by climate and environmental change. That’s an inference for veterinary practice, but it supports maintaining suspicion even outside classic hot spots. (publichealth.lacounty.gov)

Expert-style guidance from feline infectious disease literature is fairly consistent on prevention and management, even if prospective treatment trials are lacking. The ABCD guideline on rare systemic mycoses in cats describes itraconazole as the first-choice agent for histoplasmosis and emphasizes prolonged systemic antifungal therapy. Cornell adds a useful nuance for client education: indoor living lowers risk, but it doesn’t eliminate it, because exposure may still occur through potting soil or unfinished basements. That matters when pet parents assume a strictly indoor cat can’t have an environmental mycosis. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinarians, the main takeaway is less about a new therapeutic breakthrough and more about disciplined recognition and communication. Histoplasmosis should stay on the differential list for cats with chronic, multisystem, or treatment-refractory disease, particularly when weight loss, respiratory signs, diarrhea, ocular abnormalities, or generalized illness cluster together. Early diagnosis can speed antifungal treatment and supportive care, while realistic counseling is essential because therapy is long, monitoring is ongoing, and outcomes vary. In practice, this is also a pharmacology story: drug selection, tolerance, duration, and follow-up can determine whether a case is manageable for the clinic, the cat, and the pet parent. (merckvetmanual.com)

What to watch: Expect continued discussion around regional case recognition, better use of antigen testing and cytology in workups, and whether newer retrospective data can clarify which cats are most likely to respond to itraconazole versus alternative antifungal strategies. (pmc.ncbi.nlm.nih.gov)